209
Participants
Start Date
September 1, 2014
Primary Completion Date
December 9, 2016
Study Completion Date
December 9, 2016
5% Iron Isomaltoside 1000
Administered according to local routines and product labeling in doses at the doctors discretion
Heleneholmsdialysen, Malmo
Morriston Hospital, Renal Department, Swansea
Lead Sponsor
Collaborators (1)
BioStata
INDUSTRY
Pharmacosmos A/S
INDUSTRY